International Session(Workshop)2(JGES・JSGE・JSH) |
Fri. November 1st 9:00 - 12:00 Room 11: Portopia Hotel South Wing Topaz |
The usefulness of endoscopic ultrasound-guided liver biopsy for diffuse liver disease | |||
Kotaro Takeshita1, Satoshi Asai1, Yohei Hosoda2 | |||
1Department of Gastroenterology, Tane General Hospital, 2Department of Surgery, Tane General Hospital | |||
[Subjects] Recently, the usefulness of endoscopic ultrasound-guided liver biopsy (EUS-LB) for diffuse liver disease has been reported. We conducted a single-center retrospective study to clarify the clinical outcomes of EUS-LB. [Methods] We analyzed the clinical outcomes of all patients who underwent EUS-LB between August 2019 and March 2024. We also compared the quality of specimens collected from the first 10 consecutive cases of EUS-LB and the 10 consecutive cases in which percutaneous liver biopsy (PCLB) was performed. [Results] EUS-LB was performed in 34 patients with a median age of 59.5 (IQR, 50.8-70.8) years. Fine needle biopsy needle 19G was used in most cases. In most cases, one puncture was performed in each lobe. Both the rate of technical success and the pathological diagnosability were 100%. Adverse events included mild intra-abdominal bleeding in one patient (2.9%). The EUS-LB vs. PCLB is shown below. The median number of complete portal tracts was 12 (8.3-15.8) vs. 10 (7.5-13.3), p=0.45. The median total specimen length was 65 (61.5-75.3) mm vs. 42 (38-44.5) mm, p<0.01 and the median specimen area was 45.35 (41.0-48.9) mm2 vs. 33.2 (32.5-36.1) mm2, p=0.02, that was significantly better in the EUS-LB. [Conclusion] EUS-LB is useful in terms of diagnostic performance and safety. Further accumulation of case numbers is desirable. |
|||
Index Term 1: Endoscopic ultrasound Index Term 2: liver biopsy |
|||
Page Top |